The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses
SCIE
SCOPUS
- Title
- The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses
- Authors
- Shin, Eui-Cheol; Han, Ji Won; Kang, Wonseok; Kato, Takanobu; Kim, Seong-Jun; Zhong, Jin; Kim, Seungtaek; Park, Su-Hyung; Sung, Pil Soo; Watashi, Koichi; Park, Jun Yong; Windisch, Marc P.; Oh, Jong-Won; Wakita, Takaji; Han, Kwang-Hyub; Jang, Sung Key
- Date Issued
- 2020-03
- Publisher
- MDPI
- Abstract
- Hepatitis C virus (HCV) infects similar to 71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/105619
- DOI
- 10.3390/v12030302
- ISSN
- 1999-4915
- Article Type
- Article
- Citation
- VIRUSES-BASEL, vol. 12, no. 3, 2020-03
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.